M&A Deal Summary |
|
|---|---|
| Date | 2021-08-19 |
| Target | CNX Therapeutics |
| Sector | Life Science |
| Buyer(s) | Inflexion |
| Sellers(s) | Sunovion Pharmaceuticals. |
| Deal Type | Divestiture |
SEARCH BY
| Category | Private Equity Firm |
|---|---|
| Founded | 1999 |
| PE ASSETS | 10.0B GBP |
| Size | Mega |
| Type | Sector Agnostic |
Inflexion is a private equity firm that specializes in investments in UK-based founder and family-owned businesses. Broad areas of interest include consumer products/services, business services, healthcare, industrials, technology, and financial services. The Firm's target investment size is £10 to £500 million. Inflexion was formed in 1999 and is based in London.
| DEAL STATS | # |
|---|---|
| Overall | 94 of 124 |
| Sector: Life Science M&A | 3 of 5 |
| Type: Divestiture M&A Deals | 5 of 7 |
| Country: United Kingdom M&A | 86 of 105 |
| Year: 2021 M&A | 12 of 14 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-06-07 |
Mecenat
Göteborg, Sweden Mecenat is a marketing technology company connecting students, alumni and young professionals in Sweden with well-known brands by providing access to unique and relevant discounts. Mecenat was founded in 1998 and is based in Göteborg, Sweden. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-09-16 |
Medivet
Watford, United Kingdom Medivet is a provider of healthcare services in US with operates over 160 practices. Medivet was founded in 1987 and is based in Watford, United Kingdom. |
Sell | - |
| Category | Company |
|---|---|
| Founded | 1984 |
| Sector | Life Science |
| Employees | 2,100 |
| Revenue | 1.3B USD (2008) |
Sunovion is a pharmaceutical company dedicated to discovering, developing and commercializing therapeutic products that advance the science of medicine in the central nervous system (CNS) and respiratory disease areas and improve the lives of patients and their families.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 2 |
| Sector: Life Science M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 2 of 2 |
| Country: United Kingdom M&A | 1 of 1 |
| Year: 2021 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2016-08-31 |
Cynapsus Therapeutics
Toronto, Ontario, Canada Cynapsus Therapeutics, Inc. is a specialty central nervous system pharmaceutical company that has been developing a fast-acting, easy-to-use, sublingual thin film for the on-demand management of debilitating OFF episodes associated with PD. |
Buy | $624M |
